Company / Shareholders' Equity
Chemed Corp. Shareholders' Equity History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$979.4M
FY2025
5-year range
$623.3M / $1.1B
FY2021-FY2025
Trend
-12.5%
vs FY2024
Sector context
#89 of 166
Health Care
What the data says
At $979M, Chemed Corp.'s shareholders' equity ranks #89 of 166 in the Health Care sector. Shareholders' Equity has fluctuated over the past 10 years, ranging from $524M in FY2016 to $1.1B in FY2024.
Based on SEC 10-K filings.
$979M in FY2025 with a 5-year CAGR of +1.7%.
Declined from $1.1B to $979M over the past 2 years.
Health Care sector context is included.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- +7.0%
- 5-Year CAGR
- +1.7%
- 10-Year CAGR
- -
Sector benchmark
#89 of 166 in Health CareTop 54% of 166This company $979.4M Sector average $5.3B
▼
-81.4% below sector average
Key checks
Key Insights
- 5-year CAGR of +1.7%, indicating consistent growth.
- In FY2025, shareholders' equity decreased 12.5% year-over-year.
- Ranks #89 out of 166 companies in the Health Care sector.
- Peak shareholders' equity was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score 4.70 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $979.4M | -12.5% |
| FY2024 | $1.1B | +1.0% |
| FY2023 | $1.1B | +38.7% |
| FY2022 | $798.7M | +28.1% |
| FY2021 | $623.3M | -30.8% |
| FY2020 | $901.2M | +24.0% |
| FY2019 | $726.6M | +22.9% |
| FY2018 | $591.3M | +9.4% |
| FY2017 | $540.4M | +3.1% |
| FY2016 | $524.1M | +2.1% |
As of FY2025 · SEC 10-K · Updated Mar 29, 2026